GSK has spent slightly more on lobbying this year compared with 2023. The company spent $3.87 million in the first three ...

Kennedy Jr. has his way, get ready for even more anti-pharma rhetoric and potential instability at ... FDA and has called for ...

GSK reiterated its full-year guidance after its new HIV and cancer treatments lifted profit ahead of analysts’ expectations ...

British pharmaceutical company GSK said on Wednesday that it has agreed ... of the Zantac state court product liability cases pending against GSK," the company said in a statement.

British pharmaceutical company GSK on Wednesday said it swung into a ... to offset lower vaccine sales and reflected successful new product launches in oncology and HIV," chief executive Emma ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

GSK's severe asthma therapy Nucala could ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...

a second-generation anti-histamine and research product of UCB Pharma (Belgium) was launched under a co-marketing agreement. In the same year Glaxo received recognition from the Ministry of ...

Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from ...